Author: Fried S. Kozer E. Nulman I. Einarson T.R. Koren G.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.27, Iss.3, 2004-01, pp. : 197-202
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Banach Ryan Boskovic Radinka Einarson Thomas Koren Gideon
Drug Safety, Vol. 33, Iss. 1, 2010-01 ,pp. :
A meta-analysis has found no increase in cancer rates with certolizumab pegol or golimumab
Reactions Weekly, Vol. 1, Iss. 1398, 2012-01 ,pp. :
By Römkens Tessa E.H. Kampschreur Milou T. Drenth Joost P.H. van Oijen Martijn G.H. de Jong Dirk J.
Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. :